Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine

Clinical trial NCT07203755 · RECRUITING

Trial details

NCT number: NCT07203755
Sponsor: CanSino Biologics Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diphtheria, Tetanus and Acellular Pertussis Epidemic Meningitis Haemophilus Influenzae Type B Infection

Start date: 2025-12-19
Primary completion: 2029-02-01
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.